trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma
Published 1 year ago • 208 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
2:49
trimm-2 update: talquetamab daratumumab in r/r multiple myeloma
-
2:58
monumental-2: talquetamab plus pomalidomide in r/r multiple myeloma
-
10:11
monumental-1: talquetamab in r/r multiple myeloma
-
3:04
monumental-1 update: talquetamab in r/r multiple myeloma
-
0:45
majestec-2 update: teclistamab plus lenalidomide in r/r multiple myeloma
-
0:42
talquetamab treatment in patients with r/r myeloma with prior exposure to t-cell-directed therapies
-
5:49
magnetismm-3 extended follow up results: elranatamab monotherapy in r/r multiple myeloma
-
6:41
video von der dgn: welche rolle spielt vitamin d bei multipler sklerose?
-
6:39
real world experiences of patients treated with teclistamab | shonali midha, md | ims 2023
-
58:00
know your myeloma immunotherapy: teclistamab and other bispecifics
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
0:46
2-year follow-up of majestec-1: teclistamab in r/r multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
1:00
the recent fda approval of teclistamab for r/r multiple myeloma
-
0:52
the future of daratumumab in multiple myeloma
-
2:03
results of the phase 2 trial of daratumumab in multiple myeloma
-
2:44
myeloma qol through induction and maintenance
-
2:44
dual-targeting bispecific antibody alnuctamab in r/r multiple myeloma
-
1:01
car-t: myeloma toxicities
-
5:54
redirectt-1 results: teclistamab talquetamab in r/r multiple myeloma
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma